Parkinson's disease causes both movement and cognitive deficits, and for a long time both were thought to be caused by the ...
Lewy body dementia affects more than one million people in the United States. It has two forms: Dementia with Lewy bodies and ...
The study claims to be the first in the world to combine AI and optogenetics in Parkinson’s diagnosis and treatment.
In Parkinson's disease, certain dopamine-producing neurons in the brain die off, disrupting movement | Microbiology ...
Novartis is returning to the alpha-synuclein protein as a possible treatment for Parkinson’s disease, signing a licensing deal worth up to $2.2bn for Arrowhead Pharmaceuticals’ preclinical candidate.
Korean researchers have uncovered compelling evidence that oral bacteria, once colonized in the gut, can affect neurons in ...
Researchers have demonstrated the potential of a technology that integrates AI and optogenetics as a tool for precise ...
Oral bacteria, once colonised in the gut, can affect neurons in the brain and potentially trigger Parkinson's disease, ...
Airborne particles cause toxic clumps of proteins in the human brain that are hallmarks of Lewy body dementia, a new study ...
The Brighterside of News on MSN
Scientists use AI and optogenetics to make major breakthrough in Parkinson's treatment
A South Korean research group has reported in a new paper that artificial intelligence and light-based genetic tools can work ...
The findings suggest that targeting the oral–gut microbiome could lead to novel strategies for preventing or treating the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results